Education
About Us
Working with TipRanks
Follow Us
China Resources Pharmaceutical Group Ltd. (DE:640)
FRANKFURT:640
Total Valuation
China Resources Pharmaceutical Group Ltd. has a market cap or net worth of €3.59B. The enterprise value is ―.
Market Cap€3.59B
Enterprise Value―
Share Statistics
China Resources Pharmaceutical Group Ltd. has 6,282,510,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,282,510,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China Resources Pharmaceutical Group Ltd.’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.45%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)5.45%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee3.77M
Profits Per Employee49.97K
Employee Count72,700
Asset Turnover1.00
Inventory Turnover5.86
Valuation Ratios
The current PE Ratio of China Resources Pharmaceutical Group Ltd. is 10.10. China Resources Pharmaceutical Group Ltd.’s PEG ratio is -0.80.
PE Ratio10.10
PS Ratio0.00
PB Ratio0.62
Price to Fair Value0.70
Price to FCF-860.45
Price to Operating Cash Flow1.72
PEG Ratio-0.80
Income Statement
In the last 12 months, China Resources Pharmaceutical Group Ltd. had revenue of 274.18B and earned 3.57B in profits. Earnings per share was 0.56.
Revenue274.18B
Gross Profit43.30B
Operating Income12.90B
Pretax Income11.63B
Net Income3.57B
EBITDA15.45B
Earnings Per Share (EPS)0.56
Cash Flow
In the last 12 months, operating cash flow was 18.37B and capital expenditures -1.13B, giving a free cash flow of -35.78M billion.
Operating Cash Flow18.37B
Free Cash Flow-35.78M
Free Cash Flow per Share>-0.01
Dividends & Yields
China Resources Pharmaceutical Group Ltd. pays an annual dividend of €0.006, resulting in a dividend yield of 5.5%
Dividend Per Share€0.006
Dividend Yield5.5%
Payout Ratio29.78%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.39
52-Week Price Change-17.65%
50-Day Moving Average0.57
200-Day Moving Average0.62
Relative Strength Index (RSI)51.75
Average Volume (3m)0.00
Important Dates
China Resources Pharmaceutical Group Ltd. upcoming earnings date is Aug 21, 2025, TBA Not Confirmed.
Last Earnings DateMar 26, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend DateMay 28, 2025
Financial Position
China Resources Pharmaceutical Group Ltd. as a current ratio of 1.41, with Debt / Equity ratio of 143.03%
Current Ratio1.41
Quick Ratio1.13
Debt to Market Cap2.00
Net Debt to EBITDA3.62
Interest Coverage Ratio0.00
Taxes
In the past 12 months, China Resources Pharmaceutical Group Ltd. has paid 2.69B in taxes.
Income Tax2.69B
Effective Tax Rate0.23
Enterprise Valuation
China Resources Pharmaceutical Group Ltd. EV to EBITDA ratio is 5.95, with an EV/FCF ratio of 6.42.
EV to Sales0.34
EV to EBITDA5.95
EV to Free Cash Flow6.42
EV to Operating Cash Flow5.24
Balance Sheet
China Resources Pharmaceutical Group Ltd. has €17.48B in cash and marketable securities with HK$73.43B in debt, giving a net cash position of €55.95B billion.
Cash & Marketable Securities€17.48B
Total DebtHK$73.43B
Net Cash€55.95B
Net Cash Per Share€8.91
Tangible Book Value Per Share€11.62
Margins
Gross margin is 15.80%, with operating margin of 4.70%, and net profit margin of 1.30%.
Gross Margin15.80%
Operating Margin4.70%
Pretax Margin4.24%
Net Profit Margin1.30%
EBITDA Margin5.64%
EBIT Margin4.65%
Analyst Forecast
The average price target for China Resources Pharmaceutical Group Ltd. is €0.69, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€0.69
Price Target Upside23.21% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―